Water → tert-butyl (3S,5R)-3-{[(7-chlorothieno[3,2-b]pyridin-6-yl)carbonyl](2-methylpropyl)amino}-5-(morpholin-4-ylcarbonyl)piperidine-1-carboxylate
反応式
[CH3:1][CH:2]([CH3:26])[CH2:3][NH:4][C@H:5]1[CH2:10][C@@H:9]([C:11]([N:13]2[CH2:18][CH2:17][O:16][CH2:15][CH2:14]2)=[O:12])[CH2:8][N:7]([C:19]([O:21][C:22]([CH3:25])([CH3:24])[CH3:23])=[O:20])[CH2:6]1.C(N(C(C)C)CC)(C)C.[Cl:36][C:37]1[C:42]([C:43](Cl)=[O:44])=[CH:41][N:40]=[C:39]2[CH:46]=[CH:47][S:48][C:38]=12.O>ClCCl>[Cl:36][C:37]1[C:42]([C:43]([N:4]([CH2:3][CH:2]([CH3:26])[CH3:1])[C@H:5]2[CH2:10][C@@H:9]([C:11]([N:13]3[CH2:18][CH2:17][O:16][CH2:15][CH2:14]3)=[O:12])[CH2:8][N:7]([C:19]([O:21][C:22]([CH3:23])([CH3:24])[CH3:25])=[O:20])[CH2:6]2)=[O:44])=[CH:41][N:40]=[C:39]2[CH:46]=[CH:47][S:48][C:38]=12参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
tert-Butyl (3S,5R)-3-[(2-methylpropyl)amino]-5-(morpholin-4-ylcarbonyl)piperidine-1-carboxylate (100 mg) and diisopropylethylamine (0.095 ml) were dissolved in dichloromethane (3 ml), a solution of 7-chlorothieno[3,2-b]pyridine-6-carbonyl chloride (70 mg) in dichloromethane (2 ml) was added dropwise, and the mixture was stirred at room temperature for 1 hr. The reaction mixture was poured into water, and the mixture was extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, and the fraction eluted with ethyl acetate was concentrated under reduced pressure to give the object compound (120 mg).
後処理
- extractionthe mixture was extracted with ethyl acetate
- dry with materialThe extract was dried over anhydrous sodium sulfate
- customthe solvent was evaporated under reduced pressure
- washthe fraction eluted with ethyl acetate
- concentrationwas concentrated under reduced pressure
出典と根拠
- ORDレコード
- ord-a7705331e6564f69a059ead2c35660f9
- 出典データセット
- uspto-grants-2012_12
- 特許番号
- US08329691B2
反応ノート
読み込み中…